ReP USP - Resultado da busca

Filtros : "DOENÇA DE CROHN" "Bertges, Erika Ruback" Removido: "FSP" Limpar

Filtros

USP affiliated authors
- azevedo, matheus freitas cardoso de (1)
- damião, aderson omar mourão cintra (1)
- feres, omar (1)
- parra, rogério serafim (1)
- queiroz, natalia sousa freitas (1)

Collaboration
Normalized affiliation
Non normalized affiliation
- centro universitário saúde abc, santo andré (1)
- federal university of goiás, goiânia (1)
- federal university of juiz de fora, juiz de fora (1)
- federal university of minas gerais, belo horizonte (1)
- federal university of rio grande do sul, porto alegre (1)

Artigo de periodico
Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study (2022)
Parra, Rogério Serafim; Chebli, Júlio Maria Fonseca; Queiroz, Natália Sousa Freitas; Damião, Aderson Omar Mourão Cintra; Azevedo, Matheus Freitas Cardoso de; Chebli, Liliana Andrade; Bertges, Erika Ruback; Alves Junior, Antonio José Tiburcio; Ambrogini Junior, Orlando; Silva, Bianca Loyo Pona Schiavetti da; Lubini, Marcio; Bafutto, Mauro; Flores, Cristina; Vilela, Eduardo Garcia; Boratto, Sandra Felice; Gasparetti Júnior, Newton Luiz Tricarico; Steinwurz, Flavio; Carvalho, Nayara Salgado; Féres, Omar; Rocha, José Joaquim Ribeiro da
Source: BMC Gastroenterology. Unidades: FMRP, FM
Subjects: DOENÇA DE CROHN, ENTEROPATIAS INFLAMATÓRIAS, INTESTINOS, TERAPIA BIOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARRA, Rogério Serafim et al. Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study. BMC Gastroenterology, v. 22, 2022Tradução . . Disponível em: https://doi.org/10.1186/s12876-022-02280-3. Acesso em: 18 nov. 2024.
APA
Parra, R. S., Chebli, J. M. F., Queiroz, N. S. F., Damião, A. O. M. C., Azevedo, M. F. C. de, Chebli, L. A., et al. (2022). Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study. BMC Gastroenterology, 22. doi:10.1186/s12876-022-02280-3
NLM
Parra RS, Chebli JMF, Queiroz NSF, Damião AOMC, Azevedo MFC de, Chebli LA, Bertges ER, Alves Junior AJT, Ambrogini Junior O, Silva BLPS da, Lubini M, Bafutto M, Flores C, Vilela EG, Boratto SF, Gasparetti Júnior NLT, Steinwurz F, Carvalho NS, Féres O, Rocha JJR da. Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study [Internet]. BMC Gastroenterology. 2022 ; 22[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s12876-022-02280-3
Vancouver
Parra RS, Chebli JMF, Queiroz NSF, Damião AOMC, Azevedo MFC de, Chebli LA, Bertges ER, Alves Junior AJT, Ambrogini Junior O, Silva BLPS da, Lubini M, Bafutto M, Flores C, Vilela EG, Boratto SF, Gasparetti Júnior NLT, Steinwurz F, Carvalho NS, Féres O, Rocha JJR da. Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study [Internet]. BMC Gastroenterology. 2022 ; 22[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s12876-022-02280-3

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024